Current Issue
Volume: 38
Number: 4
Index: December 2010
Clinical Focus:Respiratory Care
Editorial Calendar
December 2010
Clinical Focus: Respiratory Medicine
  • Asthma and the athlete
    • Vocal cord dysfunction
    • Exercise-induced asthma
    • Exercise-induced bronchospasm
  • COPD
    • Obesity and COPD
    • Relationship between COPD and nutrition intake
  • Treatment options for steroid-induced osteoporosis in men
  • Treatments for asthma
    • Bronchodilators, anticholinergics
    • Corticosteroids
    • Metered-dose vs other types of inhalers
  • Respiratory infections in winter sports athletes
  • Asthma in elite athletes
  • Pulmonary rehabilitation and physical activity
  • Fitness and long-term oxygen therapy/lung transplantation
  • Airflow function and the metabolic syndrome
View More
Submission deadline: November 05
Fast-Track deadline: November 15
Fast-Track
About
Fast-Track peer review is available for those papers requiring immediate review (for an additional fee). Complete peer review is finalized in 1-2 weeks and comments are provided to the author within 72 hours of their receipt by the editorial office. Authors are asked to submit a revised manuscript within 10-12 days. Accepted manuscripts are processed within 2-3 weeks, published online within 3 business days of final author approval, and in print in the next available issue.
Submissions
Submit your FAST-TRACK manuscript online today. It's fast, it's easy! Just follow the detailed instructions, fill in all the required fields, and upload your manuscript.
Get started NOW!
Contacts
Libraries:
[email protected]

Reprints:
[email protected]

Subscriptions:
[email protected]

Supplements:
[email protected]

Document Delivery Services
120216-2010:

[email protected]

Editorial:
[email protected] [email protected]

Website:
[email protected]

Managing Director:
John Elduff
Phone: 610-889-3732
Fax: 1-866-297-3168
[email protected]

General Information
Phone: 610-889-3730
Fax: 1-866-297-3168
1235 Westlakes Drive
Suite 320
Berwyn, PA 19312
doi: 10.3810/psm.2021.12.6
The Physician and Sportsmedicine: Volume 36: No.1
Pfizer Steps Up Stem-Cell Research Plans
The newly launched Pfizer Regenerative Medicine unit will be based in both the United Kingdom and United States with a mission to "discover and develop a new generation of regenerative medicines."1 With plans for a team of 70 researchers (40 UK-based scientists specializing on vision and hearing, and 30 US based specializing on cardiovascular disease, diabetes, and cancer), Pfizer's chief scientific officer Ruth McKernan says the company plans to invest $100 million in the next 5 years via the research unit.1

(read)

Back to the table of contents for the December 2021 issue